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Abstract 
 Background: the diagnosis of tuberculosis pleural effusion continues 
to be a challenge in clinical practice in many parts of the world. In part due 
to the use of diagnostic tools with poor sensitivity and specificity. Bio-
markers of pleural effusion due to inflammation caused by Mycobacterium 
Tuberculosis such as adenosine deaminase activity has the potential to 
optimize the diagnostic approach of tuberculosis pleural effusion. Objective: 
to describe the diagnostic accuracy of adenosine deaminase activity among 
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adult patients with pleural effusion. Design: a chart-review cross-sectional 
study. Methods: we retrospectively reviewed patient charts from the Internal 
Medicine Department Ambulatory Center in a Tertiary Care Hospital in 
Buenos Aires, Argentina from june-1993 to december-1995.  We included 91 
patients with pleural exudates in which adenosine deaminase activity 
measurement was performed. We evaluated the sensitivity, specificity, 
positive and negative predictive value, positive and negative likelihood ratios 
and accuracy of adenosine deaminase activity compared to the reference 
standard. Results: 34/91 pleural effusions were due to tuberculosis (39%). 
Mean +/- SD pleural effusion adenosine deaminase activity levels were 
higher in the tuberculosis group vs. Non tuberculosis group (99.2 ± 37.4 U/l 
vs.51.6 ± 68.7, p< 0.0001). The best cutoff value for pleural fluid adenosine 
deaminase activity using ROC curve results (AUC=0,86) was 50 u/l yielding 
sensitivity (97%), specificity (70%), positive predicted value 67%, negative 
predicted value (97%), positive likelihood ratio (3.3) and negative likelihood 
ratio (.04). Conclusion: given the successful use of the adenosine deaminase 
activity test in pleural fluid, makes this test a highly recommended option for 
the diagnosis approach in tuberculosis pleural effusion. 
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deaminase activity sensitivity, specificity 
 
Introduction  
 Tuberculosis (TB) caused by Mycobacterium tuberculosis (MBT) is 
the leading cause of death from infectious diseases worldwide, accounting 
for 3 million deaths per year (Sundre P, 1992). Argentina is a country with a 
medium incidence TB (Abbate EH, 2007), however mortality has remained 
constant with 1,050 deaths per year (INER Argentina, 2007). TB pleural 
effusion is an important extrapulmonary manifestation of the disease and in 
many parts of the world the most common cause following by lymph node 
involvement (Mlika-Cabanne N, 1995; Moudgil H, 1994).  
 The diagnosis of pleural TB is still challenging in clinical practice. 
Traditional diagnostic methods, based on high clinical suspicion, Chest 
XRay pattern (Siddiqi K, 2003) and a positive sputum smear, are very useful 
for the diagnosis of pulmonary TB; however, they have low yield in the case 
of pleural effusion due to TB. The diagnosis of TB pleural effusion is made 
by identifying the presence of tubercle bacilli in the sputum (acid-fast 
bacillus (AFB) smear), the pleural fluid, or the pleural biopsy specimen, or 
by demonstrating the existence of granulomas in the pleural biopsy specimen 
(Epstein DM, 1987).It increases the cost of patient care because it needs the 
presence of an adecuate team and facilities for its performance, as well as a 
pathological anatomy laboratory and an experienced pathologist in this field 
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in order to interpret the findings (Diacon AH, 2003; Valdes L, 1993) and 
also all these tests are time consuming. 
 Recognition of the difficulty in diagnosing pleural TB led to a search 
for methods that would optimize the approach of pleural effusion in patients 
with a suspected TB infection. Of note among these procedures are those, 
such as Adenosine Deaminase Activity (ADA) in pleural fluid which 
identifies an inflammatory process triggered by MBT (Bañales JL, 1991; 
Ungerer JPJ, 1994; Seibert AF, 1991). The most recent study, a meta-
analysis by Lian QL and co-workers, shows a very good accuracy in 
measuring ADA in pleural effusion to diagnose TB pleural effusion. 
Nevertheless the best cutoff they found was 40 U/L given a positive 
likelihood (LH) of 9, 03 and negative LH ratio of 0,01 which are important 
values to consider (Liang QL, 2008).However in our country the suggested 
cutoff value for ADA in pleural fluid is 60 U/L (Abbate E, 2009), which 
might be supported in  the available literature (Riantawan P, 1999). 
 The present study was performed to add data in our country to find 
the best cutoff for ADA measurement in pleural fluid to diagnose A TB 
pleural effusion. 
 
Materials and methods 
 Patients: We reviewed the records of patients admitted to the 
Internal Medicine Department in a Tertiary Care Hospital in Buenos Aires, 
Argentina, from June of 1993 to December of 1995, who had pleural 
effusion as the diagnosis made at the time of discharge. There were three 
internal medicine specialists, who reviewed the patient´s charts. All of them 
who had exudates by Ligth criteria (Light RW, 1972) and modified Ligth 
criteria (Light RW, 1983) in pleural fluid samples taken at the time of 
addmition and in which the ADA measurement were included.   The patients 
included in this study in that period of time, were participating in a diagnosis 
protocol of pleural effusion at the hospital, where ADA and others markers 
were measured. These markers include glucose, LDH, cholesterol and 
proteins measured both in blood and pleural fluid. Cytology, pathology and 
cultures from pleural fluid were performed. 
 Gold Standard Criteria for Pleural Effusion Diagnosis: The 
diagnosis of a TB pleural effusion was made by the reference standard and 
was considered positive by the presence of one of the following criteria: 
1. Smear positive for AFB and/or A positive culture for TB both in 
pleural fluid and/or histology from the pleura and/or an internal 
mammary chain lymph node. 
2. Tuberculosis granuloma in both pleural and/or internal mammary 
lymph node, showing epithelioid macrophages and Langerhans giant 
cells along with lymphocytes, plasma cells, maybe a few 
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polymorphonuclear leucocytes, fibroblasts with collagen, and 
characteristic caseous necrosis in the center. 
3. Smear positive for AFB or TB positive culture from both sputum 
and/or BAL. 
4. Clinical response to treatment defined as diminution in the amount of 
pleural effusion without evidence of new active disease elsewhere, 
within two to four months from the beginning of the treatment and 
the patient becoming afebrile in the first few weeks. 
 
ADA Measurements 
 ADA was measured the by spectrophotometry method based on the 
Guisti and Galanti method of enzymatic analysis (Giusti G and Galanti B, 
1984; Giusti G, 1971).  The sample was centrifuged; 25 μL of the pleural 
fluid supernatant was placed into a test tube together with 500 μL of an 
adenosine solution. The mixture was heated at 37ºC for 60 minutes, and the 
reaction was then interrupted by the addition of a phenolnitroprusside 
solution and a hypochlorite solution. Then it was heated at 37ºC for 30 
minutes. The reading of the quantity of ammonia liberated by the ADA 
action was measured with the aid of a spectrophotometer at a wavelength of 
620 nm and converted to U/L for statistics analysis. 
 
Other causes of Pleural Effusion 
 Other causes of pleural effusion were classified as previously 
defined: cancer (Bielsa S, 2008; Diacon AH, 2003; Ferrer J, 2005), 
complicated para-pneumonic and empyema (Colice GL, 2000), pulmonary 
embolism (Romero-Candeira S, 2002) and uremic pleural effusions (Berger 
HW, 1975).  
 
Statistical Analysis 
 We used a convenience sample for this study and did not perform a 
priori sample size calculation.  
1. Primer analysis:  a description of the population (age, sex, previous 
diagnosis) and  
2. ADA levels across the reference groups. The results were expressed 
as mean ± SD and compared using Student’s T test. 
3. ROC curves results (AUC) 
4. The Scientific Geigy table determined the sensitivity, specificity, 
positive and negative predictive values, likelihood ratios 
 We used EPI INFO and IBM SPSS version 20 for all statistical 
analyses, The parameters were reported as % and 95% confidence interval; 
all P values were two sided and values of < 0.05 were considered statistically 
significant.  
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Results 
 Ninety-one patients with pleural effusions were included; see flow 
chart (Figure 1). Three of them were excluded because a diagnosis could not 
be done. Eighty eight patients were included. 
Figure 1: Flow chart of the study 
 
 
The etiologies into two groups were: those caused by TB and those 
caused by other etiology, named as Non TB. In the first group, we found 34 
pleural effusions due to TB (39%) and in the former group 54 caused by Non 
TB etiologies (61%), cancer being the most common cause (28%) (Table 1). 
Table 1: Pleural effusion characteristics, n=91 
*Lung (n=8); Breast (n=7); Lymphoma (n=5); Unknown origin (n=3); Pancreas (n=1) and 
Melanoma (n=1) 
 
Groups Etiology N (%) ADA (U/L)mean ±SD 
TB (n=34) Tuberculosis 34 (39) 99,3±37,4 
Non-TB (n=57) 
Cancer* 25 (28) 34,54 ±25,36 
Complicated Parapneumonic 16 (18) 40,70 ±26,46 
Empyema 10(11) 123 ±133,58 
Pulmonary embolism 2 (2) 18,25 ±10,25 
Uremic 1 (1) 23 
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 The pleural fluid ADA levels (Mean ± SD) in TB pleural effusion as 
99.26 ± 37.44 U/L and in Non TB pleural effusion cases (Figure 2 and Table 
2), it was 51.56 ± 68.67 (highly significant, P < 0.0001) 
Figure 2: dispersion values of ADA levels in both groups 
 
Table 2: ADA levels (Mean ± SD) in both groups 
 
 The best cut off value of pleural fluid ADA level confirming on 
ROC´s curve was 50 U/L (Figure 3). 
Figure 3: ROC curve for ADA values 
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DATA Non TB TB 
n 54.0 34.0 
Media (U/L) 51.6 99.3 
SD 68.7 37.4 
Minim 7.0 49.0 
Median 30.0 99.0 
Maxim 478.0 185.0 
P < 0.0001.   
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 Taken into account the cutoff value of 50 U/L the false positive 
etiologies, which means non TB etiologies, were: cancer, empyema (mostly 
Pneumococcus etiology) and parapneumonic effusions; being the most 
common empyema (Table 3) 
Table 3: False positive etiologies 
 
 Table 4 shows the diagnostic accuracy: sensitivity, specificity, 
positive predicted value (PPV), negative predicted value (NPV), positive 
Likelihood ratio (PLR) and negative Likelihood ratio (NLR) for an ADA´s 
cut off of 50 U/L in pleural fluid, being  sensitivity, specificity, PPV, NPV, 
PLR and NLR of 0,97, 0,70, 0, 67, 0,97, 3,28 and 0,04 respectively. 
Etiology ADA U/l 
Lymphoma 94 
Lung cancer 104 
Paraneumónico 88 
Empyema (due to actinomyces) 478 
Parapneumonic effusions 50 
Lymphoma 69 
Breast cancer 59 
Parapneumonic effusions 67 
Empyema (due to pneumococcus) 195 
Empyema (due to pneumococcus) 74 
Empyema (due to pneumococcus) 112 
Empyema (due to pneumococcus) 82 
Lymphoma 63 
Parapneumonic effusions 98 
Empyema 97 
Empyema 88 
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Table 4: ADA diagnostic accuracy 
 
Discussion 
 Despite the efforts to control tuberculosis and reduce its spread, the 
lack of accurate laboratory diagnosis hinders this effort. The diagnosis of 
tuberculosis is  still the detection of the appropriate organism and/or a 
positive culture of M tuberculosis (Kim TC, 1984), which is not only time 
consuming, but also has a low rate of finding the bacillus, depending on the 
sample evaluated.  The problem is more difficult in the diagnosis of extra 
pulmonary tuberculosis such as a TB pleural effusion. For the etiological 
confirmation of TB pleural disease, cytology and culture, Mantoux test, 
pleural biopsy (Donohoe RF, 1958) and histopathology evaluation are still 
the most common used tools. In order to add evidence in the usefulness of 
adenosine deaminase activity in pleural fluid (Piras MA, 1978) for the 
diagnosis of tuberculosis pleural effusion, we carried out this retrospective 
study in which the values of pleural fluid ADA level in tuberculosis were 
significantly elevated when compared with other etiologies. In our study, the 
cut-off for ADA´s activity was established on 50 U/L, because it has not only 
a high sensitivity and specificity, but also a high NPV. The NPV is low as 
well, giving the idea that those patients with ADA level below 50 U/L 
unlikely have TB as offending agent. The prevalence of pleural TB in our 
work was of 39 % being the most prevalent infection in the population we 
evaluated. Our results in respect to the diagnostic value of the dosage of 
ADA in the pleural fluid could be applied in a population with a different 
prevalence if we consider the statistical data not dependent of the dosage of 
ADA. The negative LH ratio was 0.04, which would discard TB in the 
majority of the pleural effusions with ADA values of 50 u/l.- 
 In respect of the false positive we found, highlight purulent pleural 
effusions (45.75 %), paraneumonic pleural effusions (25 %) and lymphomas 
(18.75%), which coincides with literature (Valdes L, 1993; Bañales JL, 
1991).  
 Regarding the diagnostic methods used, we had the major yield with 
the pleural biopsy in patients with TB (16 positive biopsies 25= 64%) while 
the culture of the pleural fluid was positive only in 2% of the cases. 
Parameter %                         (95% CI) 
Sensitivity 97.1 (91.4-100) 
Specificity 70.4 (58.2-82.5) 
PPV 67.4 (54.2-80.5) 
NPV 97.4 (92.5-100) 
Likelihood ratio (+) 3.3 (2.7-3.9) 
Likelihood ratio (-) 0.04 (.01-0.30) 
Accuracy (AUC) 0,86 (0,79-0,94) 
Prevalence 39  
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 We highlight the high yield of cytology in the pleural fluid to 
diagnose cancer, it was positive in 90 % of the cases (18 of the 20 patients) 
 The patients considered as tuberculosis individuals based on the 
response to empiric treatment had a clinical high pre test in all the cases and 
5 of the 9 patients had as well pathological findings compatible with TB such 
as high lymphocytic count, few mesothelial cells in the fluid and a chronic 
infiltrate in the pleural biopsy. 
 There are other publications where the cut off is below this value (40 
U/L) and nearly the same sensitivity and NPV (Bañales JL, 1991; Ungerer 
JPJ, 1994; Chander A, 2012; Kaisemann MC, 2004; Ocaña I, 1983). In 
Argentina, the determination of the ADA levels are not performed in the 
majority of public hospitals and the cut off recommendation is 60 U/L given  
a sensitivity and specificity of 0, 95 and 0, 96 respectively; nevertheless there 
are no studies in our country to support this value. The recommendation in 
our country is to perform the test in selected cases 14. The results of this 
study indicate that in a population with relatively high prevalence of 
tuberculosis and those patients with high risk of TB pleurisy, the analysis of 
ADA levels in pleural fluid constitutes a useful marker for the diagnosis of 
TB, which, in addition, can be made quickly and at a low cost (Agrawal S, 
2012; Maldhure BR, 1994). We defined high risk patients as the ones having 
TB or those with an epidemiology and a clinical course compatible with TB 
and also with a large amount of lymphocytes and a few mesothelial cells in 
pleural fluid and/or chronic indeterminate infiltrate in pleural histology. We 
treat them as TB serositis, until proven otherwise. 
 Given the knowledge regarding the diagnosis of a TB pleural effusion 
and the publications showing the successful use of the ADA test in pleural 
fluid instead of others methods (Moon JW, 2005; Liu KT, 2007; Morisson P, 
2008), its simplicity, low cost and quickly available results, makes this  test a 
very good option in patients like the above mentioned. We encourage 
physicians and other health care professional, to use this method in our 
country and take an ADA cut-off value of 50 U/L based in this study or the 
best current evidence of 40 U/L. 
 One limitation of our study is that all the cases in the TB group were 
not confirmed by the gold standard method (histopathological evaluation of 
pleural biopsy) used to confirm TB pleurisy. This could have introduced 
some bias in the selection of this group of patients. 
 
Conclusion 
 In our population and our laboratories the cut off was significant for 
an ADA value of 50 u/l. 
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 The most important finding in our paper is the highly negative 
predictive value (97.94 %), which lets us discard with high certainty the TB 
etiology in pleural effusions with ADA values lower than 50 u/l. 
 The sensitivity we found of 97.06% allows us to start empiric 
treatment while we wait for the definite diagnosis with a low possibility of 
making a mistake. These finding in the epidemiologic context and a 
compatible clinical presentation, are to be considered as a possible TB 
infection in patients with a pleural effusion with ADA values higher than 50 
U/L. This is sustained by the fact that the false positive results that were 
found correspond to other pathologies easily diagnosed by other methods. 
The importance of this is based on the fact that there are multiple studies that 
shows the elevated probability to develop active pulmonary TB in patients 
with these characteristic and who did not receive treatment (Siebert AF, 
1991). 
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